DOSIERUNGSPLAN EINES S1P-REZEPTORAGONISTEN

European patent · EP1819326 · Deleted

Register entry

Publication number
EP1819326
Application number
EP05826219
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Nov 28, 2005
Published
Aug 22, 2007
Granted
Jul 2, 2014
Deleted
Jul 2, 2014
Reason
Revoked in opposition
IPC classes
A61K 31/135 (2006.01)
A61P 37/06 (2006.01)
A61K 31/397 (2006.01)
Priority
US 631483 P 29.11.2004
PCT application
PCT/US2005/043044 28.11.2005
PCT publication
WO2006/058316 01.06.2006
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jun 25, 2024

    Change

    Published in Swissreg on 25.06.2024

  2. Dec 11, 2015

    Change

    Published in Swissreg on 11.12.2015

  3. Jul 2, 2014

    Granted

    Published in Swissreg on 02.07.2014

Parties

Holder

Novartis AG

Corporate Intellectual Property Lichtstrasse 35, 4056 Basel

Inventor

KOVARIK, John, M.

CH-4056 Basel

APPEL-DINGEMANSE, Silke

CH-4123 Allschwil

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.